Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic
- Status
- COMPLETED
- Phase
- PHASE3